8102
-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Vascular Health and Risk Management
(2,748,409) Views
Editor in Chief Professor Roland Asmar
1178-2048
Evaluation of efficacy and safety of fixed dose lovastatin and niacinER combination in Asian Indian dyslipidemic patients: a multicentric study
Manoj Sharma, Deepika R Sharma, Vikram Singh, RB Panwar, HS Hira, Bishav Mohan, Naveen Kumar, SK Sharma, Rajeev Gupta
Vascular Health and Risk Management 2006, 2:87-93
25 January 2006
Effects of eprosartan on target organ protection
Alejandro de la Sierra
Vascular Health and Risk Management 2006, 2:79-85
25 January 2006
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes
Catherine A Schnabel, Matthew Wintle, Orville Kolterman
Vascular Health and Risk Management 2006, 2:69-77
25 January 2006
Insulin glargine in the treatment of type 1 and type 2 diabetes 59
Anthony H Barnett
Vascular Health and Risk Management 2006, 2:59-67
25 January 2006
Ximelagatran: direct thrombin inhibitor
Shir-Jing Ho, Tim A Brighton
Vascular Health and Risk Management 2006, 2:49-58
25 January 2006
Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?
Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, Gregory A Volturo
Vascular Health and Risk Management 2006, 2:39-48
25 January 2006
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
Ryan C Neal, Peter H Jones
Vascular Health and Risk Management 2006, 2:31-38
25 January 2006
Noninvasive assessment of preclinical atherosclerosis
Helen A Lane, Jamie C Smith, J Stephen Davies
Vascular Health and Risk Management 2006, 2:19-30
25 January 2006
Treatment of severe sepsis: where next? Current and future treatment approaches after the introduction of drotrecogin alfa
Todd W Rice
Vascular Health and Risk Management 2006, 2:3-18
25 January 2006
Editorial: Incidence of stroke after myocardial infarction ||FREE PAPER||
Reza Tabrizchi
Vascular Health and Risk Management 2006, 2:1-2
13 May 2006
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
